CRYSTAL CUNNINGHAM: Open Payments
NPI 1275249310 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,849 in 144 payments from 20 companies in 2025. Trend: 2023 $931 · 2024 $1,636 · 2025 $2,849
Food & beverage: $2,655Education: $193
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 47 | $849 |
| Janssen Biotech, Inc. | 19 | $605 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $266 |
| Phathom Pharmaceuticals, Inc. | 23 | $214 |
| Madrigal Pharmaceuticals | 6 | $135 |
| Biocon Biologics Inc | 4 | $104 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Celltrion USA Inc. | 5 | $95 |
| Lilly USA, LLC | 3 | $71 |
| Aimmune Therapeutics, Inc. | 4 | $71 |
Products named: TREMFYA, RINVOQ, VOQUEZNA, ENTYVIO, SKYRIZI, DUPIXENT, LINZESS, REZDIFFRA.
Industry payments across OK — which companies pay providers there.
